(Q24336354)

GOA release 2020-03-11

1 reference

Qin Wang

1

0 references

Yongjing Chen

2

0 references

Fang Xie

3

0 references

Yan Ge

4

0 references

Lei Chen

5

0 references

Hongya Wu

6

0 references

Qiuxia Qu

7

0 references

Xuefeng Wang

8

0 references

Xueguang Zhang

Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

9

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Cytokine

0 references

volume

36

0 references

issue

1-2

0 references

page(s)

23-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021

Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CYTO.2006.10.006

7 January 2021